Related Experiment Video
Updated: Jul 19, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
Polynucleotides Suppress Inflammation and Stimulate Matrix Synthesis in an In Vitro Cell-Based Osteoarthritis Model
Sree Samanvitha Kuppa1,2,3, Hyung-Keun Kim2,3, Ju-Yeon Kang2,3
1Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Republic of Korea.
Polynucleotides (PN) show potential for treating osteoarthritis (OA) by reducing inflammation and cartilage degradation. This study found PN inhibits key inflammatory pathways and promotes cartilage matrix components in an OA cell model.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoarthritis (OA) involves cartilage degeneration, chondrocyte hypertrophy, and inflammation, mediated by NF-κB and Smad signaling pathways.
- Polynucleotides Highly Purified Technology (PN-HPT) offers a promising approach for OA treatment, utilizing purified polynucleotide agents.
- The precise mechanisms of polynucleotides (PN) in OA treatment require further elucidation.
Purpose of the Study:
- To investigate the efficacy and underlying mechanisms of a specific polynucleotide sodium agent (CONJURAN) in an in vitro osteoarthritis cell model.
- To evaluate the impact of PN on chondrocyte inflammation, hypertrophy, and extracellular matrix (ECM) homeostasis.
- To explore the modulation of NF-κB and Smad signaling pathways by PN in the context of OA.
Main Methods:
- Human articular chondrocytes (HC-a) were stimulated with interleukin-1β (IL-1β) to create an OA cell model, with or without PN treatment.
- Cell viability was assessed using the CCK-8 assay.
- Inflammatory markers (nitric oxide, MMP3, MMP13, iNOS, COX-2) and ECM components (aggrecan, collagen II) were analyzed via ELISA, qPCR, Western blot, and immunofluorescence.
Main Results:
- PN treatment inhibited IL-1β-induced downregulation of aggrecan (ACAN) and collagen type II (COL2A1) expression.
- PN significantly reduced the expression of pro-inflammatory mediators, including MMP3, MMP13, iNOS, and COX-2.
- PN partially inhibited the NF-κB pathway while upregulating the Smad2/3 pathway, indicating a dual mechanism of action.
Conclusions:
- Polynucleotides (PN) demonstrate significant anti-inflammatory effects and chondroprotective properties in an OA cell model.
- PN exerts its therapeutic effects by modulating both the NF-κB and Smad signaling pathways.
- PN, particularly agents like CONJURAN, holds potential as a novel therapeutic strategy for osteoarthritis treatment.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
Osteoclasts in Bone Remodeling
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...

